Liyue Huang

Liyue Huang is a seasoned professional in drug metabolism and pharmacokinetics (DMPK) with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Sr. Director of DMPK at Vigil Neuroscience since June 2022, Liyue previously held the position of Director of DMPK at Foghorn Therapeutics, Inc. from September 2019 to June 2022. Liyue has also worked as Associate Director at Epizyme, Principal Scientist, and Senior Scientist at Amgen, as well as a Scientist at AstraZeneca. Liyue began a career in research as a Postdoc at GSK. Academic qualifications include a Ph.D. in Toxicology from the University of Kentucky and a Bachelor's degree in Medicine from Zhejiang University.